Upregulated expression and function of the α 4 β 1 integrin in multiple myeloma cells resistant to bortezomib
出版年份 2020 全文链接
标题
Upregulated expression and function of the
α
4
β
1 integrin in multiple myeloma cells resistant to bortezomib
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-06-05
DOI
10.1002/path.5480
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resistance to proteasome inhibitors and other targeted therapies in myeloma
- (2018) Craig T. Wallington-Beddoe et al. BRITISH JOURNAL OF HAEMATOLOGY
- From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
- (2018) Niels van Nieuwenhuijzen et al. CANCER RESEARCH
- Spectrum and functional validation of PSMB5 mutations in multiple myeloma
- (2018) Santiago Barrio et al. LEUKEMIA
- Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
- (2017) C S Chim et al. LEUKEMIA
- The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
- (2016) V. Hoyos et al. BLOOD
- Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance
- (2016) B. Paiva et al. BLOOD
- Integration of Novel Agents into the Care of Patients with Multiple Myeloma
- (2016) Robert Z. Orlowski et al. CLINICAL CANCER RESEARCH
- Immune Therapies in Multiple Myeloma
- (2016) Shaji K. Kumar et al. CLINICAL CANCER RESEARCH
- NF-κB dysregulation in multiple myeloma
- (2016) Geoffrey M. Matthews et al. SEMINARS IN CANCER BIOLOGY
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
- (2015) M Martínez-Moreno et al. LEUKEMIA
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
- (2015) Tadeusz Robak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel strategies to target the ubiquitin proteasome system in multiple myeloma
- (2015) Susanne Lub et al. Oncotarget
- Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis
- (2014) A. Ghobadi et al. BLOOD
- Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
- (2013) D Koyama et al. LEUKEMIA
- Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
- (2013) H A F Stessman et al. LEUKEMIA
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function
- (2012) David García-Bernal et al. JOURNAL OF PATHOLOGY
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells
- (2011) N E Franke et al. LEUKEMIA
- Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy
- (2011) Patricia Balsas et al. LEUKEMIA RESEARCH
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Evolutionary Conserved Regulation of HIF-1β by NF-κB
- (2011) Patrick van Uden et al. PLoS Genetics
- Classical and/or alternative NF- B pathway activation in multiple myeloma
- (2010) Y. N. Demchenko et al. BLOOD
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- (2010) M Ri et al. LEUKEMIA
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma
- (2009) D Gutman et al. LEUKEMIA
- Induction of integrin β1expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma
- (2008) Morito Kurata et al. AMERICAN JOURNAL OF HEMATOLOGY
- Regulation of hypoxia-inducible factor-1α by NF-κB
- (2008) Patrick van Uden et al. BIOCHEMICAL JOURNAL
- Bortezomib-Resistant Nuclear Factor- B Activity in Multiple Myeloma Cells
- (2008) S. Markovina et al. MOLECULAR CANCER RESEARCH
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started